| Year |
Citation |
Score |
| 2017 |
Havelin J, Imbert I, Sukhtankar D, Remeniuk B, Pelletier I, Gentry J, Okun A, Tiutan T, Porreca F, King T. Mediation of movement-induced breakthrough cancer pain by IB4 binding nociceptors in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28438966 DOI: 10.1523/Jneurosci.1212-16.2017 |
0.662 |
|
| 2015 |
Remeniuk B, Sukhtankar D, Okun A, Navratilova E, Xie JY, King T, Porreca F. Behavioral and Neurochemical Analysis of Ongoing Bone Cancer Pain in Rats. Pain. PMID 25955964 DOI: 10.1097/J.Pain.0000000000000218 |
0.605 |
|
| 2015 |
Ding H, Hayashida K, Suto T, Sukhtankar DD, Kimura M, Mendenhall V, Ko MC. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. British Journal of Pharmacology. 172: 3302-12. PMID 25752320 DOI: 10.1111/bph.13124 |
0.44 |
|
| 2014 |
Sukhtankar DD, Lee H, Rice KC, Ko MC. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain Psychopharmacology. 231: 1377-1387. PMID 24217900 DOI: 10.1007/S00213-013-3341-0 |
0.556 |
|
| 2013 |
Sukhtankar DD, Zaveri NT, Husbands SM, Ko MC. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain. The Journal of Pharmacology and Experimental Therapeutics. 346: 11-22. PMID 23652222 DOI: 10.1124/jpet.113.203984 |
0.306 |
|
| 2013 |
Sukhtankar D, Ko MC. Pharmacological investigation of NOP-related ligands as analgesics without abuse liability Acs Symposium Series. 1131: 393-416. DOI: 10.1021/bk-2013-1131.ch018 |
0.392 |
|
| 2011 |
Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Molecular Pain. 7: 81. PMID 22014040 DOI: 10.1186/1744-8069-7-81 |
0.614 |
|
| 2011 |
Ondoua A, Hanlon K, Largent-Milnes T, Sukhtankar D, King T, Mantyh P, Vanderah T. CB2 receptor agonists act as a disease-modifying treatment by attenuating breast cancer-induced bone pain and improving bone health in a murine model of breast cancer metastases The Journal of Pain. 12: P51. DOI: 10.1016/J.Jpain.2011.02.207 |
0.666 |
|
| Show low-probability matches. |